Cargando…
Targeting chemoattractant chemokine (C–C motif) ligand 2 derived from astrocytes is a promising therapeutic approach in the treatment of neuromyelitis optica spectrum disorders
INTRODUCTION: Aquaporin-4 immunoglobulin G (AQP4-IgG)-induced astrocytes injury is a key mechanism in the pathogenesis of neuromyelitis spectrum disorder (NMOSD), and although CCL2 is involved, its specific role has not been reported. We aimed to further investigate the role and potential mechanisms...
Autores principales: | Wang, Yupeng, Bian, Jiangping, Yao, Mengyuan, Du, Li, Xu, Yun, Chang, Haoxiao, Cong, Hengri, Wei, Yuzhen, Xu, Wangshu, Wang, Huabing, Zhang, Xinghu, Geng, Xingchao, Yin, Linlin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10086366/ https://www.ncbi.nlm.nih.gov/pubmed/37056770 http://dx.doi.org/10.3389/fimmu.2023.1144532 |
Ejemplares similares
-
CSF-S100B Is a Potential Candidate Biomarker for Neuromyelitis Optica Spectrum Disorders
por: Wei, Yuzhen, et al.
Publicado: (2018) -
Profile and potential role of novel metabolite biomarkers, especially indoleacrylic acid, in pathogenesis of neuromyelitis optica spectrum disorders
por: Bian, Jiangping, et al.
Publicado: (2023) -
Thymic Involution and Altered Naive CD4 T Cell Homeostasis in Neuromyelitis Optica Spectrum Disorder
por: Chang, Haoxiao, et al.
Publicado: (2021) -
Commentary: Targeting chemoattractant chemokine (C–C motif) ligand 2 derived from astrocytes is a promising therapeutic approach in the treatment of neuromyelitis optica spectrum disorders
por: Zhang, Jingdan, et al.
Publicado: (2023) -
Anti-NMDA receptor encephalitis concomitant with myelin oligodendrocyte glycoprotein antibody diseases: A retrospective observational study
por: Du, Li, et al.
Publicado: (2020)